Clinical Trials Logo

Clinical Trial Summary

Heart failure with preserved ejection fraction (HFpEF) is characterised by impaired diastolic function. A recent clinical trial has demonstrated multiple beneficial outcomes in HFpEF patients receiving personalised accelerated pacing from indwelling permanent pacemakers, including symptomatic improvement, objective reductions in NT-proBNP level and AF-burden. The investigators aim to determine the underlying mechanisms behind these documented effects, to investigate the acute intracardiac haemodynamic response to temporary multisite pacing in HFpEF participants and to gain further mechanistic insight with additional haemodynamic, electrical and echocardiographic data collection during temporary pacing in this cohort. This will all provide valuable information towards new potential targets of therapy.


Clinical Trial Description

In this research study, the investigators will perform a one-off temporary pacing procedure in the catheter lab at St Thomas' Hospital in patients with heart failure with preserved ejection fraction (HFpEF). During the short procedure, the investigators will pace the heart at different heart rates and from different parts of the heart. The investigators will measure the change in pressure inside the heart in response to each pacing site/mode and rate. Altogether, the investigators aim to find out how different pacing modes and heart rates impact how well the heart fills and pumps in HFpEF. The study will provide valuable information about the underlying mechanisms of pacing in HFpEF, which could significantly influence the future direction of HFpEF management. Specifically, it will help the investigators to understand what types of pacemaker and pacing site or pacing mode may be chosen in HFpEF patients requiring pacing, which accounts for around 20% of all HFpEF patients. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06467266
Study type Interventional
Source Guy's and St Thomas' NHS Foundation Trust
Contact Prof Christopher Aldo Rinaldi, MD, MBBS, FRCP, FHRS
Phone 0207188 7188
Email aldo.rinaldi@gstt.nhs.uk
Status Not yet recruiting
Phase N/A
Start date July 1, 2024
Completion date October 31, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT06338943 - Middle-aged Women With Adverse Pregnancy Outcomes and Heart Failure With Preserved Ejection Fraction
Completed NCT02435667 - Resistance Training in HFpEF N/A
Recruiting NCT06057623 - Neuromuscular Fatigue and Exercise Capacity in Patients With Type 2 Diabetes Mellitus and HFpEF
Recruiting NCT06215586 - Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction (Cycle-2-PEF) Phase 2
Recruiting NCT05888233 - Allopurinol Improves Heart Function in African Americans With Resistant Hypertension Phase 2